Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing

Sponsor
Hospital for Special Surgery, New York (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00198185
Collaborator
Musculoskeletal Transplant Foundation (Other)
0
1

Study Details

Study Description

Brief Summary

Hypothesis: The use of cascade platelet-rich fibrin matrix (PRFM) on medium and large sized rotator cuff tears will improve patient results versus the control results by 50%.

The purpose of this study is to examine the effect of PRFM on rotator cuff repairs. Since locally applied platelet-derived growth factor (PDGF) has shown early promise in enhancing tendon and ligament healing in anterior cruciate ligament (ACL) and medial collateral ligament (MCL) reconstruction, the investigators believe that locally applied PRFM will enhance the quality of rotator cuff repairs.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Placement of Platelet Rich Fibrin Matrix During Arthroscopic Rotator Cuff Surgery
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
The Evaluation of Cascade PRFM on Rotator Cuff Healing
Study Start Date :
Jan 1, 2005
Primary Completion Date :
Jan 1, 2005
Study Completion Date :
Jan 1, 2005

Outcome Measures

Primary Outcome Measures

  1. L'Insalata: preoperatively, 6 weeks, 3 months post-operatively, 12 months post-operatively []

  2. American Shoulder and Elbow Surgery (ASES) Patient Survey: preoperatively, 6 weeks, 3 months post-operatively, 12 months post-operatively []

Secondary Outcome Measures

  1. Ultrasound (power Doppler imaging): 6 weeks, 3 months post-operatively []

  2. Manual muscle testing using a dynamometer: preoperatively, 3 months post-operatively, 6 months post-operatively []

  3. ASES Physician Survey: preoperatively, 3 months post-operatively, 12 months post-operatively []

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients 45 years of age and older who have failed conservative treatment for rotator cuff pathology.

  • Patients in this study will have full thickness rotator cuff tears that are classified arthroscopically as medium (1 to 3 cm) or large (3 to 5 cm) and that are treated with arthroscopic repair.

Exclusion Criteria:
  • Patients who have undergone revision procedures, mini-open, or open procedures will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital for Special Surgery New York New York United States 10021

Sponsors and Collaborators

  • Hospital for Special Surgery, New York
  • Musculoskeletal Transplant Foundation

Investigators

  • Principal Investigator: Russell F. Warren, MD, Hospital for Special Surgery, New York

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier:
NCT00198185
Other Study ID Numbers:
  • 24087
First Posted:
Sep 20, 2005
Last Update Posted:
Jan 4, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Hospital for Special Surgery, New York
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2018